{"schema_version":"ap.public_observed_evidence.v1","canonical_record":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq","record_type":"independent_public_company_observation","name":"Avalo Therapeutics, Inc.","disclosure":"AuthorityPrompt independently observes public sources. The company has not claimed or approved this public record. Publication does not prove that any AI provider retrieved or cited it, and does not establish commercial losses or permanent model behavior.","mcp_version":"1.0","resources":[{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/manifest.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/ai-sitemap.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/facts.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/sources.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/provenance.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/confidence.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/consensus.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/trust-graph.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/authorityprompt.txt","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/authorityprompt.jsonld","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/authorityprompt.md","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/verification.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/updates.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/llm-instructions.txt","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/conflicts.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/conflict-summary.txt","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/answer-blocks.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/response-contract.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/render-contract.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/agent-instructions.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/capabilities.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/citations.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/agreement.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/freshness.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/openai.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/claude.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/gemini.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/perplexity.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/response-schema.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/answer-policy.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/response-priorities.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/response-variants.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/mcp/resources.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/mcp/tools.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/status.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/connector.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/trust-profile.json","access":"public_read_only"},{"uri":"https://authorityprompt.com/workspace/aw_6WqktcHV5S-hsy1Yo6ZAzi5vPbIxnNeq/structured-signals.json","access":"public_read_only"}],"authenticated_tools":"requires_corporate_authority"}